HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
HOOKIPA Pharma Inc. (HOOK) PT Lowered to $48 at RBC Capital
November 15, 2024 6:32 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on HOOKIPA Pharma Inc. (NASDAQ: HOOK) to $48.00 (from $50.00) while maintaining a Outperform rating.
The analyst comments "With enrollment wrapped up in the ph.II portion of the ongoing OL study... More
